Skip to main content

Hybrid Operating Room Market | Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.) Key Players

The global hybrid operating room market is expected to grow at a CAGR of 12.5% between 2017 and 2022. Factors driving the growth of this market include the increasing adoption of minimally invasive surgical procedures and technological advancements among others.

As of 2016, Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), Richard Wolf GmbH (Germany), MIZUHO OSI (U.S.), STERIS plc. (U.S.), NDS Surgical Imaging (U.S.), Alvo (Poland) are some of the major manufacturers in hybrid operating room market.

Analysis of the market developments between 2014 and 2017 (March) show that new product launch, agreements, and collaborations were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market position by collaborating to develop and provide technologically advanced products to its customer base. For instance, in 2017, Siemens Healthineers (Germany), received FDA clearance for its ARTIS pheno Angiography System.

Philips Healthcare is one of the leading players in the hybrid operating room market, in 2016. In order to strengthen its current position and to gain a larger share in the hybrid operating room market, the company aggressively focuses on inorganic and organic business growth strategies such as partnerships, product launches, approvals, and product deployment. In February 2017, Philips Healthcare launched Azurion, an image-guided therapy platform. Additionally, in January 2017, Philips launched its augmented-reality surgical navigation technology for spine, cranial, and trauma surgeries.

Labels:

Comments

Post a Comment

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...
Post a Comment
Read more

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...
Post a Comment
Read more

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...
Post a Comment
Read more